Higher Liposomal Membrane Fluidity Enhances the in Vitro Antitumor Activity of Folate-Targeted Liposomal Mitoxantrone
- 15 December 2008
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 6 (1), 98-104
- https://doi.org/10.1021/mp800069c
Abstract
The efficacy of folate-targeted liposomal drug delivery has not been fully achieved in part because of the slow release of the encapsulated drugs following uptake of the liposomes by target cells. Since liposomal mitoxantrone (MXN) composed of lipids with high fluidity was reported to achieve strong anticancer effects in vivo, we hypothesized that folate-targeted liposomal MXN uptake via folate receptor (FR)-mediated endocytosis could effectively release drugs into the endosomal compartment. Folate-targeted liposomal MXN was prepared using two lipids with different fluidities. MXN was released slowly from all types of liposome into PBS, indicating that the cellular uptake of MXN was considered to be in the liposomal form. Folate-targeted liposomes with high fluidity exhibited lower cellular uptake of loaded FITC-labeled dextran into FR (+) KB cells, but, when MXN was loaded, higher cytotoxicity than liposomes with lower fluidity. On the other hand, the cellular uptake of non-folate liposomes was not affected by the membrane fluidity, but higher cytotoxicity was observed in liposomal MXN with high fluidity, which suggested a higher rate of release of the drug from the liposomes. High levels of cytotoxic activity were achieved with folate-targeted liposomal MXN though the cellular uptake rate was restricted by selecting liposomes with higher lipid membrane fluidity. This finding provides a new insight into folate-targeted carrier drug delivery.Keywords
This publication has 18 references indexed in Scilit:
- Transport of anthracyclines and mitoxantrone across membranes by a flip-flop mechanismBiochemical Pharmacology, 2005
- Effect of Polyethylene Glycol Linker Chain Length of Folate-Linked Microemulsions Loading Aclacinomycin A on Targeting Ability and Antitumor Effect In vitro and In vivoClinical Cancer Research, 2005
- Controlled targeting of liposomal doxorubicin via the folate receptor in vitroJournal of Controlled Release, 2003
- Antitumor Activity of Folate Receptor-Targeted Liposomal Doxorubicin in a KB Oral Carcinoma Murine Xenograft ModelPharmaceutical Research, 2003
- Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activityNature Biotechnology, 1999
- Targeting Folate Receptor with Folate Linked to Extremities of Poly(ethylene glycol)-Grafted Liposomes: In Vitro StudiesBioconjugate Chemistry, 1999
- Overexpression of folate binding protein in ovarian cancersInternational Journal of Cancer, 1997
- Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitroBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992